OMC
CNTA

Oasis Management Company’s Centessa Pharmaceuticals CNTA Stock Holding History

Oasis Management Company’s Portfolio CNTA Stock Details CNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-110,000
Closed -$341K – 83
2022
Q4 		$341K Hold
110,000
– – 0.07% 79
2022
Q3 		$442K Buy
110,000
+52,300
+91% +$239K 0.07% 91
2022
Q2 		$281K Buy
+57,700
New +$369K 0.05% 103

Other funds holding CNTA

MVM
Medicxi Ventures Management St. Helier, Jersey $177M AUM 212.06% 1-Year Est. Return
GA
General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
VVA
Vida Ventures Advisors Boston, Massachusetts $29.4M AUM 93.58% 1-Year Est. Return
OMC
OUP Management Company Bala Cynwyd, Pennsylvania $44.5M AUM 55.11% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Oasis Management Company's CNTA Position: Q1 2023 in Review

Oasis Management Company sold out of Centessa Pharmaceuticals (CNTA) in Q1 2023, closing a stake of 110,000 shares — an estimated $341K sold.

Oasis Management Company first reported a position in CNTA in Q2 2022 and held it in 3 quarters. The position peaked at $442K in Q3 2022. 44 funds tracked by Wall St. Rank hold CNTA as of Q1 2023.

  • Oasis Management Company reported no remaining Centessa Pharmaceuticals position as of Q1 2023 after selling out during the quarter.
  • Oasis Management Company sold 110,000 Centessa Pharmaceuticals shares in Q1 2023, an estimated $341K.
  • Oasis Management Company first reported a position in Centessa Pharmaceuticals in Q2 2022 and held it in 3 quarters.
  • Oasis Management Company's Centessa Pharmaceuticals position peaked at $442K in Q3 2022.
  • 44 funds tracked by Wall St. Rank held Centessa Pharmaceuticals as of Q1 2023.

Based on Oasis Management Company's 13F filing for Q1 2023, filed 15 May 2023.